Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
Hepatocellular carcinoma is one of the cancers that kill people in the global population. Icaritin, a small molecule drug approved by NMPA, has demonstrated potential anti-HCC effects. However, its underlying molecular mechanisms remain unclear. We employed a multi-omics approach in this study, incl...
Saved in:
Main Authors: | Zhong Xue (Author), Fan Zhang (Author), Shaohua Xu (Author), Minyong Chen (Author), Mingzuo Wang (Author), Ming Wang (Author), Fayong Ke (Author), Zhaoshuo Chen (Author), Mingji Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
by: Minglu Liu, et al.
Published: (2022) -
Hyaluronic acid-modified liposomes Potentiated in-vivo anti-hepatocellular carcinoma of icaritin
by: Xiaoduan Sun, et al.
Published: (2024) -
Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
by: Minglu Liu, et al.
Published: (2023) -
Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
by: Shikang Wang, et al.
Published: (2019) -
Systematic Investigation of Berberine for Treating Hepatocellular Carcinoma Based on Network Pharmacology
by: Mu Jie, et al.
Published: (2019)